217 related articles for article (PubMed ID: 8376766)
21. Augmentation of lymphokine-activated killer cell activity by lentinan.
Tani M; Tanimura H; Yamaue H; Tsunoda T; Iwahashi M; Noguchi K; Tamai M; Hotta T; Mizobata S
Anticancer Res; 1993; 13(5C):1773-6. PubMed ID: 8267381
[TBL] [Abstract][Full Text] [Related]
22. Requirement of thiol compounds as reducing agents for IL-2-mediated induction of LAK activity and proliferation of human NK cells.
Yamauchi A; Bloom ET
J Immunol; 1993 Nov; 151(10):5535-44. PubMed ID: 8228244
[TBL] [Abstract][Full Text] [Related]
23. Enhancement of immunostimulatory activity by dual substitution of C8-substituted guanine ribonucleosides: correlation with increased cytokine secretion.
Pope BL; Chourmouzis E; Lee S; Goodman MG
J Immunother Emphasis Tumor Immunol; 1995 Feb; 17(2):98-108. PubMed ID: 7647961
[TBL] [Abstract][Full Text] [Related]
24. IL-4 regulation of perforin gene expression and BLT-esterase production in alpha CD3-induced activated killer cells.
Ting CC; Liang SM; Wang J; Chen YY; Hargrove M; Xu N
Biotechnol Ther; 1994-1995; 5(3-4):99-115. PubMed ID: 8608327
[TBL] [Abstract][Full Text] [Related]
25. Local and systemic immune response to inactivated Candida albicans in mice.
Scaringi L; Rosati E; Cornacchione P; Fettucciari K; Sabatini R; Biondi R; Mezzasoma L; Valiani M; D'Errico P; Marconi P
Nat Immun; 1995 Sep; 14(5-6):234-49. PubMed ID: 8933818
[TBL] [Abstract][Full Text] [Related]
26. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
27. Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immune cells.
Chen CP; Boyadjieva NI; Advis JP; Sarkar DK
Alcohol Clin Exp Res; 2006 Nov; 30(11):1925-32. PubMed ID: 17067358
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of long-term cultured activated killer cells induced by anti-T3 antibody.
Yun YS; Hargrove ME; Ting CC
J Immunol; 1988 Aug; 141(4):1390-7. PubMed ID: 3260924
[TBL] [Abstract][Full Text] [Related]
29. Effect of recombinant murine tumor necrosis factor on the generation of natural killer cells in bone marrow cultures.
Ayroldi E; Sorci G; Cannarile L; Riccardi C
Nat Immun; 1992; 11(2):92-104. PubMed ID: 1498522
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
[TBL] [Abstract][Full Text] [Related]
31. Alteration of human lymphokine-activated killer cell activity by manipulation of protein kinase C and cytosolic Ca2+.
McCrady CW; Li F; Grant AJ; Merchant RE; Carchman RA
Cancer Res; 1988 Feb; 48(3):635-40. PubMed ID: 3257170
[TBL] [Abstract][Full Text] [Related]
32. Lymphokine-activated killer (LAK) cell generation from peripheral blood stem cells by in vitro incubation with low-dose interleukin-2 plus granulocyte-macrophage colony-stimulating factor.
Herrera C; García-Pérez MJ; Ramirez R; Martín C; Alvarez MA; Martinez F; Gómez P; García-Castellano JM; Torres A
Bone Marrow Transplant; 1997 Mar; 19(6):545-51. PubMed ID: 9085733
[TBL] [Abstract][Full Text] [Related]
33. In vivo enhancement of murine natural killer cell activity by 7-allyl-8-oxoguanosine (loxoribine).
Pope BL; Chourmouzis E; Sigindere J; Capetola RJ; Lau CY
Int J Immunopharmacol; 1992 Nov; 14(8):1375-82. PubMed ID: 1464469
[TBL] [Abstract][Full Text] [Related]
34. Activation of murine natural killer cells and macrophages by 8-bromoguanosine.
Koo GC; Jewell ME; Manyak CL; Sigal NH; Wicker LS
J Immunol; 1988 May; 140(9):3249-52. PubMed ID: 2452203
[TBL] [Abstract][Full Text] [Related]
35. Prostaglandin E2-induced changes in the phenotype, morphology, and lytic activity of IL-2-activated natural killer cells.
Linnemeyer PA; Pollack SB
J Immunol; 1993 May; 150(9):3747-54. PubMed ID: 8386202
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-15 induces the expression of mRNAs of cytolytic mediators and augments cytotoxic activities in primary murine lymphocytes.
Ye W; Young JD; Liu CC
Cell Immunol; 1996 Nov; 174(1):54-62. PubMed ID: 8929454
[TBL] [Abstract][Full Text] [Related]
37. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-2 (IL-2) activated natural killer (A-NK) cells: binding to microvascular endothelial cells and BRM enhancement of cytolytic activity.
Brunson KW; Ohashi M; Miller CA; Kitson RP; Basse PH; Goldfarb RH
In Vivo; 1994; 8(1):71-5. PubMed ID: 8054514
[TBL] [Abstract][Full Text] [Related]
39. Synergy of human recombinant interleukin 1 with interleukin 2 in the generation of lymphokine-activated killer cells.
Crump WL; Owen-Schaub LB; Grimm EA
Cancer Res; 1989 Jan; 49(1):149-53. PubMed ID: 2783241
[TBL] [Abstract][Full Text] [Related]
40. IL-7 induces human lymphokine-activated killer cell activity and is regulated by IL-4.
Stötter H; Custer MC; Bolton ES; Guedez L; Lotze MT
J Immunol; 1991 Jan; 146(1):150-5. PubMed ID: 1670602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
